Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

lupus nephritis

- PMLiVE

GSK tops pharma access to medicines table

But corruption and intellectual property issues in developing nations

- PMLiVE

GSK first to file IL-5 antagonist for asthma

Mepolizumab submitted as a treatment for severe eosinophilic asthma

- PMLiVE

NICE backs GSK drug for leukaemia

Arzerra on course for NHS use in blood cancer

- PMLiVE

EU boost for GSK’s Ebola vaccine research

And EMA says it' poised to assess possible vaccines or treatments

- PMLiVE

GSK to sell off part of its HIV venture ViiV Healthcare

And sets out new restructure programme as US Seretide sales hit

- PMLiVE

Novartis announces departures of three execs

Follows deals to sell divisions to GSK and Lilly

- PMLiVE

GSK unit takes new ofatumumab formulation into phase III

Studied in autoimmune disorder of the skin

- PMLiVE

Trials of NewLink’s Ebola vaccine ‘imminent’

NewLink and GSK candidates only two vaccines being tested

- PMLiVE

GSK expands bioelectronics efforts with $5m challenge fund

Will support academics and small companies working to stimulate and block neural signals in organs

Sir Philip Hampton set to be new GSK chair

RBS chairman to replace Sir Christopher Gent

- PMLiVE

GSK fined $487m as Chinese probe concludes

Five former executives receive jail sentences

- PMLiVE

NICE fast-tracks GSK’s skin cancer drug Tafinlar

But only on condition the company cuts its price

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links